- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1374
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1374 companies
Daito PharmaceuticalLtd
Market Cap: JP¥37.5b
Manufactures and sells pharmaceutical products worldwide.
4577
JP¥1,250.00
7D
2.1%
1Y
7.7%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €212.7m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€8.70
7D
-2.2%
1Y
-0.7%
Devyser Diagnostics
Market Cap: SEK 2.3b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 141.00
7D
-10.2%
1Y
10.6%
Neurogene
Market Cap: US$248.4m
A clinical stage biotechnology company, develops genetic medicines for rare neurological diseases.
NGNE
US$17.82
7D
3.6%
1Y
-55.8%
Bukwang Pharmaceutical
Market Cap: ₩347.3b
Develops, produces, and sells pharmaceutical products in South Korea and internationally.
A003000
₩3,520.00
7D
-5.8%
1Y
-31.7%
Quanterix
Market Cap: US$244.4m
A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
QTRX
US$5.19
7D
-4.4%
1Y
-59.2%
Lyell Immunopharma
Market Cap: US$244.4m
A clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.
LYEL
US$12.83
7D
-2.0%
1Y
-57.5%
Immutep
Market Cap: AU$374.3m
A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.26
7D
2.0%
1Y
-25.0%
Novartis India
Market Cap: ₹21.6b
Novartis India Limited is involved in the pharmaceutical business in India.
500672
₹875.70
7D
-3.4%
1Y
-24.7%
Huons
Market Cap: ₩343.7b
Provides medical solutions for human health in Korea and internationally.
A243070
₩29,500.00
7D
-4.7%
1Y
1.2%
BNC Korea
Market Cap: ₩342.0b
Engages in the research and development, production, and sale of biomaterials for medicines in South Korea.
A256840
₩5,000.00
7D
-3.5%
1Y
-13.0%
Perspective Therapeutics
Market Cap: US$236.9m
Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.
CATX
US$3.40
7D
6.6%
1Y
-73.0%
Puma Biotechnology
Market Cap: US$236.7m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$4.84
7D
9.5%
1Y
87.6%
SCI Pharmtech
Market Cap: NT$7.2b
Together with its subsidiary, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals in Italy, the United States, Japan, Germany, Taiwan, Switzerland, China, and internationally.
4119
NT$60.20
7D
4.5%
1Y
-33.0%
Organigram Global
Market Cap: CA$326.4m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$2.36
7D
-3.3%
1Y
-1.3%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.8b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.21
7D
0%
1Y
6.1%
Egyptian International Pharmaceutical Industries
Market Cap: ج.م11.2b
Manufactures and sells pharmaceutical ampoules in Egypt and internationally.
PHAR
ج.م66.50
7D
3.7%
1Y
41.1%
Exagen
Market Cap: US$232.6m
Designs, develops, and commercializes various testing products under the AVISE brand in the United States.
XGN
US$10.89
7D
13.9%
1Y
246.8%
Sagimet Biosciences
Market Cap: US$232.2m
A clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States.
SGMT
US$7.34
7D
12.6%
1Y
160.3%
Vor Biopharma
Market Cap: US$231.3m
Operates as a clinical-stage cell and genome engineering company.
VOR
US$33.62
7D
23.4%
1Y
137.1%
Animalcare Group
Market Cap: UK£172.5m
Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.
ANCR
UK£2.50
7D
0%
1Y
6.8%
Atea Pharmaceuticals
Market Cap: US$230.9m
A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.
AVIR
US$2.93
7D
1.7%
1Y
-14.8%
Tiziana Life Sciences
Market Cap: US$230.7m
A biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States.
TLSA
US$2.06
7D
13.2%
1Y
104.0%
3D Medicines
Market Cap: HK$1.8b
A biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the People’s Republic of China.
1244
HK$7.31
7D
-9.8%
1Y
139.7%
BioDlink International
Market Cap: HK$1.8b
An investment holding company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in Mainland China and internationally.
1875
HK$2.29
7D
4.6%
1Y
17.4%
OmniAb
Market Cap: US$224.6m
A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.
OABI
US$1.61
7D
0%
1Y
-62.1%
Ouro Fino Saúde Animal Participações
Market Cap: R$1.2b
Engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil.
OFSA3
R$22.25
7D
-3.3%
1Y
6.1%
Invivyd
Market Cap: US$222.2m
A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.
IVVD
US$1.12
7D
-8.2%
1Y
-2.6%
OBI Pharma
Market Cap: NT$6.7b
A clinical stage oncology company, research and develops novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally.
4174
NT$25.35
7D
-1.7%
1Y
-65.2%
Tiansheng Pharmaceutical Group
Market Cap: CN¥1.6b
Engages in the pharmaceutical manufacturing and circulation activities.
002872
CN¥4.89
7D
-6.1%
1Y
27.3%
Windlas Biotech
Market Cap: ₹19.3b
A contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India.
WINDLAS
₹922.70
7D
-4.2%
1Y
11.1%
Highnoon Laboratories
Market Cap: PK₨61.0b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,150.55
7D
0.8%
1Y
66.9%
Shanghai Rightongene Biotechnology
Market Cap: CN¥1.5b
Shanghai Rightongene Biotechnology Co., Ltd.
688217
CN¥27.71
7D
0.04%
1Y
73.3%
JW (Cayman) Therapeutics
Market Cap: HK$1.7b
A clinical stage cell therapy company, engages in the research and development, manufacture, and marketing of cellular immunotherapy products in the People’s Republic of China.
2126
HK$4.10
7D
-17.7%
1Y
159.5%
MDxHealth
Market Cap: US$212.8m
A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.
MDXH
US$4.63
7D
11.8%
1Y
123.7%
Ventyx Biosciences
Market Cap: US$212.5m
A clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases.
VTYX
US$2.98
7D
29.6%
1Y
29.0%